Brief: Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing
21/05/2025 21:40
Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 10.9 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: [ID:n0001104659-25-051615] Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program